Impact of renal function on coronary plaque composition

Nephrology Dialysis Transplantation

Volumn 25, Issue 1, 2010, Pages 175-181

  Miyagi, Motohiro ^a   Ishii, Hideki ^a   Murakami, Ryuichiro ^a   Isobe, Satoshi ^a   Hayashi, Mutsuharu ^a   Amano, Tetsuya ^a   Arai, Kosuke ^a   Yoshikawa, Daiji ^a   Ohashi, Taiki ^a   Uetani, Tadayuki ^a   Yasuda, Yoshinari ^a   Matsuo, Seiichi ^a   Matsubara, Tatsuaki ^b   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Coronary heart disease; Integrated backscatter intravascular ultrasound; Percutaneous coronary intervention; Renal function

Indexed keywords

LIPID;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY PLAQUE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTEGRATED BACKSCATTER INTRAVASCULAR ULTRASOUND; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TISSUE CHARACTERIZATION;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CORONARY STENOSIS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LIPID METABOLISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 72949092888     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp423     Document Type: Article

References (34)

1. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615
2. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-152
3. Goldsmith DJA, Covic A. Coronary artery disease in uremia: etiology, diagnosis, and therapy. Kidney Int 2001; 60: 2059-2078
4. Best PJ, Lennon R, Ting HH et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2002; 39: 1113-1119
5. Mann JF, Gerstein HC, Pogue Jet al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636
6. Ruilope LM, Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 12: 218-225
7. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003; 108: 2154-2169
8. Shlipak MG, Heidenreich PA, Noguchi H et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002; 137: 555-562
9. Meeus F, Kourilsky O, Guerin AP et al. Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int Suppl 2000; 76: S140-S147
10. Rubenstein MH, Harrell LC, Sheynberg BV et al. Are patients with renal failure good candidates for percutaneous coronary revascular-ization in the new device era? Circulation 2000; 102: 2966-2972
11. Shaw JA, Andrianopoulos N, Duffy S et al. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents. Cardiovasc Revasc Med 2008; 9: 218-223
12. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
13. GrubergL, RaiP, Mintz GS et al. Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis. Am J Cardiol 2005; 96: 892-896
14. 2: a meta-analysis of intravascular ultrasound studies. Am J Cardiol 2007; 99: 813-816
15. Kawasaki M, Takatsu H, Noda T et al. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 2002; 105: 2487-2492
16. Sano K, Kawasaki M, Ishihara Y et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscat-ter intravascular ultrasound. J Am Coll Cardiol 2006; 47: 734-741
17. Amano T, Matsubara T, Uetani T et al. Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions: integrated backscatter intravascular ultrasound study. J Am Coll Cardiol 2007; 49: 1149-1156
18. Amano T, Matsubara T, Uetani T et al. Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. J Am Coll Cardiol Img 2008; 1: 39-45
19. Miyagi M, Ishii H, Murakami R et al. Impact of chronic statin therapy on coronary plaque composition at angiographically severe lesions: a non-randomized study focused on history of chronic statin treatment before coronary angioplasty. Clin Ther 2009; 31: 64-73
20. Imai E, Horio M, Nitta K et al. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis 2007; 50: 927-937 (Pubitemid 350130278)
21. Ryan TJ, Bauman WB, Kennedy JW et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutics Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993; 88: 2987-3007
22. Mintz GS, Nissen SE, Anderson WD et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001; 37: 1478-1492
23. Raffel OC, Tearney GJ, Gauthier DD et al. Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography. Arterioscler Thromb Vasc Biol 2007; 27: 1820-1827
24. Vaziri ND, Oveisi F, Ding YX. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 1998; 53: 1748-1754
25. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000; 35: S117-S131
26. Rigatto C, Levin A, House AA et al. Atheroma progression in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 291-298
27. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671
28. Aziz K, Berger K, Claycombe K et al. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation 2008; 117: 2061-2070
29. Davies MJ, Richardson PD, Woolf N et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993; 69: 377-381
30. Fernández-Ortiz A, Badimon JJ, Falk E et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994; 23: 1562-1569
31. Uetani T, Amano T, Ando H et al. The Correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-proceduaral myocardial infarction in patients with elective stent implantation. Eur Heart J 2008; 29: 1714-1720
32. Kawasaki M, Sano K, Okubo M et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005; 45: 1946-1953
33. Shepherd J, Kastelein JJ, Bittner V et al. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Cardiol 2008; 51: 1448-1454
34. Tonelli M, Isles C, Curhan GC et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 2004; 110: 1557-1563